Early stage cervical cancer: role of magnetic resonance imaging after conization in determining residual tumor
- 20 July 2016
- journal article
- Published by SAGE Publications in Acta Radiologica
- Vol. 57 (10) , 1268-1276
Abstract
Background Although magnetic resonance imaging (MRI) is currently indispensable in the management of cervical cancer, its role in determining residual tumor in patients with cervical cancer after conization is not well known. Purpose To evaluate the value of MRI after conization in determining residual tumor in patients with FIGO stage IA-IB1 cervical cancer. Material and Methods In this retrospective study, 55 patients underwent conization followed by preoperative MRI and definitive surgery. Two radiologists evaluated the presence of residual tumor on MRI. MRI and preoperative clinical variables were compared between patients with and without residual tumor at final pathology using Student’s t-test or Chi-square test. Association between variables and the presence of residual tumor was assessed using logistic regression analyses and receiver operating characteristic (ROC) curves. Results Residual tumor at final pathology was found in 30 (54.5%) patients. Patients with residual tumor were older, had greater SCC antigen, and more frequently had positive conization margins and identifiable tumor on MRI (P < 0.008). Multivariate analysis showed that age (P = 0.008; odds ratio [OR] = 1.140), positive conization margin (P = 0.016; OR = 11.919), and identifiable tumor on MRI (P = 0.038; OR = 6.926) were independently predictive of residual tumor. Areas under the curve (AUCs) calculated with age (0.693), SCC antigen (0.755), and identifiable tumor on MRI (0.727) were greater than lymphovascular space invasion (0.517) and histological subtype (0.520, P ≤ 0.049). Otherwise, there were no significant differences in the AUCs derived from different variables (P = 0.053–0.970). Conclusion Identifiable tumor on MRI after conization in patients with early stage cervical cancer was an independent predictor of residual tumor at final pathology.Keywords
This publication has 30 references indexed in Scilit:
- Safety of less aggressive surgery for stage IA1 squamous cell carcinoma of the cervixJournal of Obstetrics and Gynaecology Research, 2014
- Stage IB1 Cervical Cancer: Role of Preoperative MR Imaging in Selection of Patients for Fertility-Sparing Radical TrachelectomyRadiology, 2013
- Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysisEuropean Radiology, 2013
- New MR Techniques in Gynecologic CancerAmerican Journal of Roentgenology, 2013
- Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgeryGynecologic Oncology, 2011
- Revised FIGO staging for carcinoma of the cervixInternational Journal of Gynecology & Obstetrics, 2009
- Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent’s operation): A comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH)Gynecologic Oncology, 2007
- Radical vaginal trachelectomy as a fertility‐sparing procedure in women with early‐stage cervical cancer—cumulative pregnancy rate in a series of 123 womenBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?Gynecologic Oncology, 2004
- Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literatureGynecologic Oncology, 2004